CO6260077A2 - Pirimidinas biciclicas fusionadas - Google Patents
Pirimidinas biciclicas fusionadasInfo
- Publication number
- CO6260077A2 CO6260077A2 CO10015919A CO10015919A CO6260077A2 CO 6260077 A2 CO6260077 A2 CO 6260077A2 CO 10015919 A CO10015919 A CO 10015919A CO 10015919 A CO10015919 A CO 10015919A CO 6260077 A2 CO6260077 A2 CO 6260077A2
- Authority
- CO
- Colombia
- Prior art keywords
- alkyl
- hydrogen
- mono
- alkoxy
- salt
- Prior art date
Links
- 229910052739 hydrogen Inorganic materials 0.000 abstract 6
- 239000001257 hydrogen Substances 0.000 abstract 6
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 abstract 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical group N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 4
- 150000002431 hydrogen Chemical group 0.000 abstract 4
- 229910052757 nitrogen Inorganic materials 0.000 abstract 4
- 150000003839 salts Chemical class 0.000 abstract 4
- 229910052736 halogen Inorganic materials 0.000 abstract 3
- 150000002367 halogens Chemical class 0.000 abstract 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 3
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 125000005842 heteroatom Chemical group 0.000 abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 2
- 229910052760 oxygen Inorganic materials 0.000 abstract 2
- 239000001301 oxygen Substances 0.000 abstract 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- 229910052717 sulfur Chemical group 0.000 abstract 2
- 239000011593 sulfur Chemical group 0.000 abstract 2
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 125000004122 cyclic group Chemical group 0.000 abstract 1
- 125000001072 heteroaryl group Chemical group 0.000 abstract 1
- 125000005549 heteroarylene group Chemical group 0.000 abstract 1
- 125000001544 thienyl group Chemical group 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
1.- Un compuesto de fórmula (I)en donde el anillo B y la pirimidina a la cual está fusionado forman un sistema de anillos seleccionado entreen dondeR1 es hidrógeno, 1-4C-alquilo, halógeno, amino, 1-4C-alcoxi, ciano, 3-7C-cicloalquilo, 2-4C-alquenilo, 2-4C-alquinilo, 3-7C-cicloalcoxi, mono- o di-1-4C- alquilamino, mono- o di-1-4C-alquilaminocarbonilo, -C(O)NH2, -C(O)OR2 o trifluorometilo, R2 es hidrógeno o 1-4C-alquilo, R3 es hidrógeno, 1-4C-alquilo o halógeno, R5 es hidrógeno, 1-4C-alcoxi, amino, mono- o di- 1-4C-R4 R4 es fenilo o tienilo, R5 es es hidrógeno, 1-4C-alcoxi, amino, mono- o di- 1-4C-alquilamino, 1-4C-alquilo o 3-7C-cicloalquilo, R6 es hidrógeno o 1-4C-alquilo, R7 es -W-Y,W es un heteroarileno monocíclico de 5 miembros que comprende 1 átomo de nitrógeno y opcionalmente 1 o 2 heteroátomos adicionales seleccionados en forma independiente entre oxígeno, nitrógeno y azufre, y en donde el heteroarileno está opcionalmente sustituido por R8, R8 es 1-4C-alquilo o 3-7C-cicloalquilo, Y es fenilo o un heteroarilo monocíclico de 5 ó 6 miembros que comprende 1 átomo de nitrógeno y opcionalmente 1 o 2 heteroátomos adicionales seleccionados en forma independiente entre oxígeno, nitrógeno y azufre, y en donde el heteroarilo está opcionalmente sustituido por R9,R9 es 1-4C-alquilo, 1-4C-alcoxi o halógeno, o una sal, particularmente una sal aceptable para uso farmacéutico, un tautómero, o un estereoisómero de dicho compuesto, o una sal, particularmente una sal aceptable para uso farmacéutico, de dicho tautómero o dicho isómero.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN1572MU2007 | 2007-08-14 | ||
| EP07118736A EP2050748A1 (en) | 2007-10-18 | 2007-10-18 | Novel fused pyrimidines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO6260077A2 true CO6260077A2 (es) | 2011-03-22 |
Family
ID=40153211
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO10015919A CO6260077A2 (es) | 2007-08-14 | 2010-02-12 | Pirimidinas biciclicas fusionadas |
Country Status (37)
| Country | Link |
|---|---|
| US (2) | US7776864B2 (es) |
| EP (1) | EP2188291B1 (es) |
| JP (1) | JP5344637B2 (es) |
| KR (1) | KR20100053556A (es) |
| CN (1) | CN101778851B (es) |
| AR (1) | AR067945A1 (es) |
| AU (1) | AU2008288392B2 (es) |
| BR (1) | BRPI0815207A2 (es) |
| CA (1) | CA2694058C (es) |
| CL (1) | CL2008002398A1 (es) |
| CO (1) | CO6260077A2 (es) |
| CR (1) | CR11270A (es) |
| CY (1) | CY1113486T1 (es) |
| DK (1) | DK2188291T3 (es) |
| DO (1) | DOP2010000058A (es) |
| EA (1) | EA020996B1 (es) |
| EC (1) | ECSP109964A (es) |
| ES (1) | ES2396177T3 (es) |
| HN (1) | HN2010000313A (es) |
| HR (1) | HRP20121022T1 (es) |
| IL (1) | IL203163A (es) |
| MA (1) | MA31608B1 (es) |
| MX (1) | MX2010001746A (es) |
| MY (1) | MY169738A (es) |
| NZ (1) | NZ583267A (es) |
| PA (1) | PA8793201A1 (es) |
| PE (1) | PE20090944A1 (es) |
| PL (1) | PL2188291T3 (es) |
| PT (1) | PT2188291E (es) |
| RS (1) | RS52559B (es) |
| SI (1) | SI2188291T1 (es) |
| SV (1) | SV2010003483A (es) |
| TN (1) | TN2010000070A1 (es) |
| TW (1) | TWI439272B (es) |
| UA (1) | UA99735C2 (es) |
| UY (1) | UY31293A1 (es) |
| WO (1) | WO2009021992A2 (es) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2009003972A (es) * | 2006-10-19 | 2009-04-27 | Takeda Pharmaceutical | Compuesto de indol. |
| NZ583267A (en) | 2007-08-14 | 2012-03-30 | Bayer Schering Pharma Ag | Fused bicyclic pyrimidines |
| WO2009155121A2 (en) | 2008-05-30 | 2009-12-23 | Amgen Inc. | Inhibitors of pi3 kinase |
| WO2010091824A1 (en) * | 2009-02-13 | 2010-08-19 | Bayer Schering Pharma Aktiengesellschaft | Fused pyrimidines as akt inhibitors |
| AU2010213192A1 (en) * | 2009-02-13 | 2011-08-04 | Bayer Intellectual Property Gmbh | Fused pyrimidines |
| EP2413932A4 (en) * | 2009-04-01 | 2012-09-19 | Merck Sharp & Dohme | HAMMER OF ACT ACTIVITY |
| WO2010125799A1 (ja) | 2009-04-27 | 2010-11-04 | 塩野義製薬株式会社 | Pi3k阻害活性を有するウレア誘導体 |
| US20130184273A1 (en) * | 2010-07-13 | 2013-07-18 | Bayer Intellectual Property Gmbh | Bicyclic pyrimidines |
| EP2598505B1 (en) | 2010-07-28 | 2015-03-18 | Bayer Intellectual Property GmbH | Substituted imidazo[1,2-b]pyridazines |
| WO2012136776A1 (en) | 2011-04-07 | 2012-10-11 | Bayer Intellectual Property Gmbh | Imidazopyridazines as akt kinase inhibitors |
| CA2897279C (en) | 2013-01-23 | 2020-12-29 | Astrazeneca Ab | Aminopyrazine derivatives and pharmaceutical compositions thereof for use in the treatment of cancer |
| US20140274685A1 (en) | 2013-03-15 | 2014-09-18 | Bayer Cropscience Lp | Compositions, additives, and methods for mitigating or controlling seed dust |
| WO2014146144A2 (en) * | 2013-03-15 | 2014-09-18 | Bayer Cropscience Lp | Compositions, additives, and methods for mitigating or controlling seed dust |
| US10738056B2 (en) | 2017-09-15 | 2020-08-11 | Aduro Biotech Inc. | Pyrazolopyrimidinone compounds and uses thereof |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ523807A (en) | 2000-06-30 | 2004-09-24 | Wyeth Corp | Substituted-triazolopyrimidines as anticancer agents |
| US7449488B2 (en) * | 2002-06-04 | 2008-11-11 | Schering Corporation | Pyrazolopyrimidines as protein kinase inhibitors |
| US7579355B2 (en) | 2003-04-24 | 2009-08-25 | Merck & Co., Inc. | Inhibitors of Akt activity |
| WO2005100344A1 (en) | 2004-04-09 | 2005-10-27 | Merck & Co., Inc. | Inhibitors of akt activity |
| TW200618800A (en) * | 2004-08-03 | 2006-06-16 | Uriach Y Compania S A J | Heterocyclic compounds |
| JP2008510823A (ja) | 2004-08-23 | 2008-04-10 | メルク エンド カムパニー インコーポレーテッド | Ａｋｔ活性阻害剤 |
| EP1827436A4 (en) | 2004-12-15 | 2011-08-10 | Merck Sharp & Dohme | INHIBITORS OF ACT ACTIVITY |
| CA2590961C (en) * | 2004-12-28 | 2013-11-26 | Exelixis, Inc. | [1h-pyrazolo[3,4-d]pyrimidin-4-yl]-piperidine or -piperazine compounds as serine-threonine kinase modulators (p70s6k, atk1 and atk2) for the treatment of immunological, inflammatory and proliferative diseases |
| EP1850843A4 (en) | 2005-02-14 | 2012-02-15 | Merck Sharp & Dohme | INHIBITORS OF ACT ACTIVITY |
| KR100959771B1 (ko) | 2005-06-10 | 2010-05-28 | 머크 샤프 앤드 돔 코포레이션 | Ａｋｔ 활성의 억제제 |
| NZ583267A (en) | 2007-08-14 | 2012-03-30 | Bayer Schering Pharma Ag | Fused bicyclic pyrimidines |
| AU2010213192A1 (en) * | 2009-02-13 | 2011-08-04 | Bayer Intellectual Property Gmbh | Fused pyrimidines |
-
2008
- 2008-08-14 NZ NZ583267A patent/NZ583267A/en not_active IP Right Cessation
- 2008-08-14 EA EA201000298A patent/EA020996B1/ru not_active IP Right Cessation
- 2008-08-14 CA CA2694058A patent/CA2694058C/en not_active Expired - Fee Related
- 2008-08-14 JP JP2010520586A patent/JP5344637B2/ja not_active Expired - Fee Related
- 2008-08-14 CN CN2008801031086A patent/CN101778851B/zh not_active Expired - Fee Related
- 2008-08-14 TW TW097131066A patent/TWI439272B/zh not_active IP Right Cessation
- 2008-08-14 WO PCT/EP2008/060690 patent/WO2009021992A2/en not_active Ceased
- 2008-08-14 UA UAA201002746A patent/UA99735C2/uk unknown
- 2008-08-14 PA PA20088793201A patent/PA8793201A1/es unknown
- 2008-08-14 KR KR1020107003246A patent/KR20100053556A/ko not_active Abandoned
- 2008-08-14 SI SI200830848T patent/SI2188291T1/sl unknown
- 2008-08-14 ES ES08787224T patent/ES2396177T3/es active Active
- 2008-08-14 RS RS20120556A patent/RS52559B/sr unknown
- 2008-08-14 US US12/191,703 patent/US7776864B2/en not_active Expired - Fee Related
- 2008-08-14 UY UY31293A patent/UY31293A1/es not_active Application Discontinuation
- 2008-08-14 CL CL2008002398A patent/CL2008002398A1/es unknown
- 2008-08-14 MY MYPI2010000150A patent/MY169738A/en unknown
- 2008-08-14 DK DK08787224.8T patent/DK2188291T3/da active
- 2008-08-14 PT PT87872248T patent/PT2188291E/pt unknown
- 2008-08-14 HR HRP20121022AT patent/HRP20121022T1/hr unknown
- 2008-08-14 BR BRPI0815207A patent/BRPI0815207A2/pt not_active IP Right Cessation
- 2008-08-14 PL PL08787224T patent/PL2188291T3/pl unknown
- 2008-08-14 AU AU2008288392A patent/AU2008288392B2/en not_active Ceased
- 2008-08-14 MX MX2010001746A patent/MX2010001746A/es active IP Right Grant
- 2008-08-14 PE PE2008001378A patent/PE20090944A1/es not_active Application Discontinuation
- 2008-08-14 EP EP08787224A patent/EP2188291B1/en active Active
- 2008-08-15 AR ARP080103562A patent/AR067945A1/es unknown
-
2010
- 2010-01-06 IL IL203163A patent/IL203163A/en not_active IP Right Cessation
- 2010-02-12 HN HN2010000313A patent/HN2010000313A/es unknown
- 2010-02-12 MA MA32617A patent/MA31608B1/fr unknown
- 2010-02-12 CR CR11270A patent/CR11270A/es unknown
- 2010-02-12 DO DO2010000058A patent/DOP2010000058A/es unknown
- 2010-02-12 EC EC2010009964A patent/ECSP109964A/es unknown
- 2010-02-12 CO CO10015919A patent/CO6260077A2/es active IP Right Grant
- 2010-02-12 TN TNP2010000070A patent/TN2010000070A1/fr unknown
- 2010-02-12 SV SV2010003483A patent/SV2010003483A/es unknown
- 2010-03-25 US US12/731,880 patent/US8614218B2/en not_active Expired - Fee Related
-
2012
- 2012-12-13 CY CY20121101220T patent/CY1113486T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO6260077A2 (es) | Pirimidinas biciclicas fusionadas | |
| AR067946A1 (es) | Imidazoles biciclicos fusionados | |
| PE20130375A1 (es) | Compuestos de triazolopiridinas y triazolopirazinas inhibidores de c-met y composiciones de los mismos | |
| AR075253A1 (es) | Pirimidinas fusionadas, procesos de preparacion y composiciones farmaceuticas que los contiene. | |
| AR072952A1 (es) | Compuestos de 2-imino-3-metilpirrolopirimidinona fenilo-sustituida como inhibidores de bace-1, composiciones y su uso | |
| AR052232A1 (es) | Derivados de 5-heteroariltiazoles | |
| AR061923A1 (es) | Compuestos derivados de benzofuran-piperidina | |
| AR087288A1 (es) | Compuestos de tetrahidropirido-piridina y tetrahidropirido-pirimidina y su uso como moduladores de receptores de c5a | |
| PE20190656A1 (es) | Compuestos de tiazolo-piridina sustituida como inhibidores de malt1 | |
| EA200970207A1 (ru) | Соединения пиридо[2,3-d]пиримидинона и их применение в качестве pi3 ингибиторов | |
| AR068846A1 (es) | Compuestos derivados de pirrolo (2,3d)-pirimidina inhibidores de la actividad de pkb, composiciones farmaceuticas que los contienen, proceso de preparacion y uso de los mismos como agentes anticancer | |
| AR076415A1 (es) | Compuestos heterociclicos nitrogenados fusionados y su uso en el control de artropodos | |
| AR053120A1 (es) | Aminopiridinas como inhibidores de beta secretasa | |
| AR059064A1 (es) | Compuestos de tiazol, composiciones farmaceuticas que los contienen y usos en el tratamiento de enfermedades mediadas por la proteina quinasa b(pkb), tales como cancer. | |
| AR064416A1 (es) | Derivados de purina, piridina y pirimidina condensadas con heterociclos, moduladores de pka y/o pkb, composiciones farmaceuticas que los contienen, y usos para el tratamiento de enfermedades hiperproliferativas. | |
| ES2600636T3 (es) | Spiro-[1,3]-oxazinas y spiro-[1,4]-oxazepinas como inhibidores de BACE1 y/o BACE2 | |
| AR074109A1 (es) | Pirrolidinas heterociclicas agonistas de receptores de la melanocortina, composiciones farmaceuticas que las contienen y uso de las mismas en el tratamiento de la obesidad, diabetes y disfuncion erectil. | |
| CO6230982A2 (es) | Compuestos triciclicos que contienen actividad antagonista de factor de liberacion de corticotropina y composiciones farmaceuticas que los contienen | |
| CO6230986A2 (es) | Compuesto de 4-piridinona y su uso para cancer | |
| AR085615A1 (es) | Derivados de fluoropiridinona utiles como agentes antibacterianos y composiciones farmaceuticas que los contienen | |
| AR063529A1 (es) | Compuestos de pirazolina | |
| AR062965A1 (es) | Compuestos moduladores de receptores de glutamatometabotropicos mglur5, composiciones farmaceuticas que los contienen y usos terapeuticos en trastornos gastrointestinales, neurologicos y psiquiatricos agudos y cronicos | |
| AR085327A1 (es) | Inhibidores del virus de la hepatitis c | |
| MX2020001531A (es) | Nuevos compuestos hetorociclicos como inhibidores de cdk8/19. | |
| AR079497A1 (es) | Derivados fenilimidazol que comprenden un enlazante de etinileno como inhibidores de enzima pde10a |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Application granted |